Would you like to submit an article, some interesting news, or get your startup featured? Send whatever you have to “firstname.lastname@example.org”, and happy to have you featured on our newsletter (+1000 Subscribers ) !
Oncora Medical is a digital health company bringing real world data to radiation oncology. Founded in 2014, Oncora builds intuitive software tools to collect and use real world clinical data to improve outcomes for cancer patients. We are driven by our shared vision of a future where every cancer patient is offered a custom-tailored treatment plan based on their predicted treatment response.
The Delhi High Court has allowed Alembic Pharmaceuticals and Natco Pharma to export sorafenib, an active ingredient in German pharma major Bayer’s cancer drug Nexavar, and rivaroxaban, the API in its blood thinner medicine Xarelto, for research and development purposes. The patent for Nexavar and Xarelto is scheduled to end next year.
Xynomic Pharmaceuticals Holdings, a clinical stage US-China oncology drug development company, announced that Xynomic Research Institute (XRI) has successfully designed a series of potent RET kinase inhibitors by computer-assisted drug design.
Immunotherapy developer Scancell announced the initiation of and further updates to the ‘SCIB1’ phase 2 trial in patients with metastatic melanoma also receiving the checkpoint inhibitor ‘pembrolizumab’ (Keytruda) on Monday.
FarmaKology is a newsletter that brings you the latest news, research, job opportunities in the Pharma world, and much more! If you would like to be featured in the newsletter, sponsor an issue, or need anything, please feel free to get in touch with me at "email@example.com".